KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.43.

  • Idexx Laboratories' EPS (Basic) rose 2120.14% to $3.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.72, marking a year-over-year increase of 2149.0%. This contributed to the annual value of $10.77 for FY2024, which is 586.36% up from last year.
  • Idexx Laboratories' EPS (Basic) amounted to $3.43 in Q3 2025, which was up 2120.14% from $3.66 recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' EPS (Basic) registered a high of $3.66 during Q2 2025, and its lowest value of $1.57 during Q2 2022.
  • Its 5-year average for EPS (Basic) is $2.52, with a median of $2.46 in 2024.
  • As far as peak fluctuations go, Idexx Laboratories' EPS (Basic) surged by 8237.71% in 2021, and later plummeted by 3355.21% in 2022.
  • Over the past 5 years, Idexx Laboratories' EPS (Basic) (Quarter) stood at $1.91 in 2021, then grew by 8.87% to $2.08 in 2022, then increased by 12.5% to $2.34 in 2023, then grew by 12.01% to $2.62 in 2024, then surged by 30.86% to $3.43 in 2025.
  • Its last three reported values are $3.43 in Q3 2025, $3.66 for Q2 2025, and $2.98 during Q1 2025.